Trastuzumab emtansine: a game changer in HER2-positive early breast cancer.

MLA

Mano, Max. “Trastuzumab Emtansine: A Game Changer in HER2-Positive Early Breast Cancer.” Future Oncology (London, England), vol. 16, no. 32, Nov. 2020, pp. 2595–609. EBSCOhost, https://doi.org/10.2217/fon-2020-0219.

APA

Mano, M. (2020). Trastuzumab emtansine: a game changer in HER2-positive early breast cancer. Future Oncology (London, England), 16(32), 2595–2609. https://doi.org/10.2217/fon-2020-0219

Chicago

Mano, Max. 2020. “Trastuzumab Emtansine: A Game Changer in HER2-Positive Early Breast Cancer.” Future Oncology (London, England) 16 (32): 2595–2609. doi:10.2217/fon-2020-0219.